/Lists

Biotech Series C Investors & VC Firms

430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.

OrbiMed
New YorkSeed–Late Stage$1M – $75M
93 people
In-Q-Tel
WashingtonSeed–Growth$100K – $2.5M
35 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
33 people
Madrona Venture Group
SeattlePre-Seed–Series C$2M – $10M
64 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
99 people
JAFCO Group
TokyoPre-Seed–Growth
91 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
89 people
Octopus Ventures
LondonPre-Seed–Growth$130K – $1.3M
37 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
CDP Venture Capital
RomaPre-Seed–Growth
44 people
BDC Venture Capital
MontrealPre-Seed–Growth$365K – $25.6M
109 people
Abstract Ventures
San FranciscoPre-Seed–Series C$250K – $750K
6 people
Oak HC/FT
StamfordSeed–Growth
54 people
Korea Investment Partners
SeoulSeed–Series C$3M – $10M
80 people
Atinum Investment Co. Ltd.
SeoulSeries B–Growth$100K – $2M
44 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
60 people
ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people
SoftBank Group
TokyoSeries B–Growth
23 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
62 people
Bayern Kapital
LandshutSeed–Late Stage$275K – $55M
46 people
Third Rock Ventures
BostonSeed–Series C$100K – $5M
74 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.